Moors & Cabot, Inc. Vera Therapeutics, Inc. Transaction History
Moors & Cabot, Inc.
- $2.02 Billion
- Q4 2024
A detailed history of Moors & Cabot, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 5,200 shares of VERA stock, worth $187,928. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,200Holding current value
$187,928% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
190Shares Held
56MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$156 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$142 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$121 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$107 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$101 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $977M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...